Chad J. Rubin

Partner

  • Chad J. Rubin
  • Phone: +1 215 979 1204

    Read Chad J. Rubin's blog Import to Address Book

  • Duane Morris LLP
    30 South 17th Street
    Philadelphia, PA 19103-4196
    USA

Chad J. Rubin represents independent trustees of mutual funds and exchange traded funds (ETFs). He advises independent trustees with respect to their duties under the Investment Company Act of 1940 and state law. In this regard, he provides advice on a full range of matters, including governance, regulatory and compliance, contract approvals and disclosure issues. Mr. Rubin regularly counsels independent trustees with respect to industry best practices.

Mr. Rubin also has experience representing public and private companies in connection with their capital-raising activities, including public offerings and private placements of equity and debt securities. He also advises companies with respect to SEC regulations, compliance issues and other corporate and securities law matters, such as public reporting, Sarbanes-Oxley compliance and communications with analysts and investors. He has substantial experience representing public and private companies in selling and acquiring businesses.

Mr. Rubin is a 2003 graduate of the University of Pennsylvania Law School and a 2000 graduate of Duke University (B.A.).

Areas of Practice

  • Corporate Law
  • Securities Law
  • Mergers & Acquisitions
  • Mutual Funds

Representative Matters

    Mergers & Acquisitions/Securities

  • Represented Next Level Hospitality Services, a provider of culinary and environmental services in the senior living sector that specializes in skilled nursing and rehabilitation facilities, in connection with its multimillion-dollar sale to Aramark (NYSE:ARMK), the global leader in food, facilities management and uniforms.

  • Represented New York Home Health Holdings/Honor Health Network, a provider of home healthcare services, in connection with its multimillion-dollar sale by its members to Webster Capital, a financial sponsor.

  • Represented Jornaya, a leading provider of consumer behavioral data and intelligence, in its sale to Verisk (Nasdaq: VRSK), a leading data analytics provider, serving customers in insurance, energy and specialized markets, and financial services.

  • Represented DSM-Firmenich Inc., one of the world's largest producers of flavors and fragrances, in connection with its minority investment in a strategic target with an option to acquire the remainder of the company.

  • Represented Texas Hospice Holdings, LLC, a multi-state hospice facility operator, in connection with the sale of all of its outstanding equity to Amedisys Inc., a publicly-held hospice company.

  • Represented DSM-Firmenich Inc., one of the world's largest producers of flavors and fragrances, in connection with its acquisition of Agilex Holdings, Inc., a portfolio company of New York-based private equity firm MidOcean Partners.

  • Represented Unilife Corp. (Nasdaq: UNIS / ASX: UNS) in connection with its announced effort to seek strategic alternatives, culminating in a strategic collaboration with Amgen Inc. (Nasdaq: AMGN) for Unilife's wearable injectable drug delivery systems to use with Amgen's biologics and other medicines. The deal provides Unilife with investments of up to $90 million from Amgen and restructures Unilife's existing debt with OrbiMed.

  • Represented the Board of Directors of RCS Capital Corporation (NYSE: RCAP) in the proposed acquisition from VEREIT, Inc. (NYSE: VER) (formerly American Realty Capital Properties, Inc.) of its Private Capital Management Business, Cole Capital®, for $700 million.

  • Representation of the special committee of the board of directors of an NYSE-listed company, backed by a leading private equity sponsor, operating in the consumer services industry in connection with the strategic repurchase of shares from the private equity fund.

  • Represented Unilife Corp. (NASDAQ: UNIS / ASX: UNS), a developer, manufacturer, and supplier of injectable drug delivery systems, in connection with the sale, through Chapter 11 bankruptcy, of substantially all of its assets to an affiliate of OrbiMed Advisors LLC, a leading investment firm focused on healthcare, and Amgen Inc., (NASDAQ: AMGN), a leading biotechnology company that discovers, develops, manufacturers and delivers human therapeutics for patients with serious illnesses.

  • Represented Lehigh Gas Partners LP, a wholesale motor fuel distributor now known as CrossAmerica Partners LLP, in connection with its $138 million IPO.

  • Represented an NYSE MKT-traded company in its agreement to acquire a majority equity interest in a full-service investment bank in exchange for the company's contribution of its $45 million equity interest in its broker-dealer subsidiary.

  • Represented CTI Group (Holdings) Inc. (OTC: CTIG) in its $22.5 million sale to Enghouse Systems Limited (TSX: ESL) through its wholly-owned subsidiary, New Acquisitions Corporation.

  • Represented a global fragrance company in a $20 million investment in a strategic partner.

  • Represented the special committee of the Board of Directors of JAVELIN Mortgage Investment Corp. (NYSE: JMI) in a $900 million merger in which ARMOUR Residential REIT, Inc. (NYSE: ARR) acquired JAVELIN through a cash tender offer followed by an intermediate form merger.

  • Represented a leading NYSE-traded international REIT in its approximately $900 million acquisition of an NYSE-traded REIT.

  • Represented a publicly traded manufacturing company in its acquisition of a privately held manufacturing company for approximately $60 million.

  • Represented a privately held investment firm in its acquisition of a publicly held specialty finance company in an equity exchange.

  • Represented an NYSE MKT-traded company in a debt-exchange transaction.

    • Mutual Funds

  • Independent counsel to the independent trustees of mutual funds and ETFs, including a fund group with assets under management in excess of $55 billion.

  • Represented the independent trustees of a mutual fund in connection with the launch of a new multi-manager alternative strategies fund and continue to represent the independent trustees in connection with their oversight of such fund.

  • Represented the independent trustees of a mutual fund in connection with the launch of a new commodities fund and continue to represent the independent trustees in connection with their oversight of such fund.

  • Represented the independent trustees of an ETF complex in connection with the initial launch of the ETFs in 2008 and continue to represent the independent trustees in connection with their oversight of such funds.

  • Represented the independent trustees of an emerging market ETF complex in connection with the initial launch of the ETFs in 2009 and continue to represent the independent trustees in connection with their oversight of such funds.

  • Represented an NYSE-traded company in a follow-on offering of its common stock for a total capital raise of approximately $50 million.

  • Securities and general corporate counsel to publicly traded companies, including a Fortune 1000 company.

Admissions

  • Pennsylvania
  • New Jersey

Education

  • University of Pennsylvania Carey Law School, J.D., 2003
  • Duke University, B.A., 2000

Experience

  • Duane Morris LLP
    - Partner, 2012-present
    - Associate, 2009-2011
  • WolfBlock LLP
    - Associate, 2003-2009

Honors and Awards

  • Rated as a Notable Practitioner for Capital Markets: Debt and Capital Markets: Equity by IFLR1000, 2022 and 2023

  • Rated as a "Rising Star" for Capital Markets: Debt and Capital Markets: Equity by IFLR1000, 2019-2021

  • Listed in Pennsylvania Super Lawyers Rising Stars, 2014-2018

No aspect of these rankings has been approved by the Supreme Court of New Jersey. Further information on methodologies is available via these links.

Board Memberships

  • Philadelphia Regional Port Authority
    - Board Member, October 2004-October 2009